Clinical Trial Update: Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dehydroepiandrosterone (DHEA) for pulmonary hypertension in adults with chronic obstructive pulmonary disease (COPD) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• Dehydroepiandrosterone (DHEA) (dehydroepiandrosterone)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Chronic Obstructive Pulmonary Disease, Hypertension, Pulmonary | Phase 2 | Status: COMPLETED